<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00449917</url>
  </required_header>
  <id_info>
    <org_study_id>P11</org_study_id>
    <nct_id>NCT00449917</nct_id>
  </id_info>
  <brief_title>&quot;Visiobiane Anti-age&quot; Effects on Vision Parameters</brief_title>
  <official_title>Study of the Effects of &quot;Visiobiane Anti-age&quot; Dietary Supplement on Macular Pigment Optical Density, Contrast Sensibility and Visual Acuity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pileje</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pileje</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the benefits of &quot;Visiobiane Anti-age&quot; dietary
      supplement on macular pigment optical density, contrast sensibility and visual acuity.
      Additionally, the study would like to evaluate seric variations of carotenoids and the total
      antioxydant capacity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Visiobiane study is a randomized trial of 30 participants designed to assess the effects of
      oral supplementation of macular xanthophylls (lutein and zeaxanthin) and omega-3 LCPUFAs for
      the eyes protection. The study will enroll healthy participants aged 45 to 55 years. 15
      subjects will be assigned in placebo group and 15 in experimetal group (Visiobiane anti-age).
      They will be supplemented for 24 weeks
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <primary_completion_date type="Actual">July 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>macular pigment optical density</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>contrast sensibility</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual acuity</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>seric carotenoids concentrations</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total antioxidant capacity</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>influence of SR-B1 genetic polimorphism</measure>
  </secondary_outcome>
  <enrollment>30</enrollment>
  <condition>Macular Pigment Optical Density</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lutein</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DHA</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vitamins</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy caucasian men

          -  age : 45-55

          -  BMI &lt; 25

        Exclusion Criteria:

          -  non healthy

          -  retinian and/or visual anomaly

          -  Ocular media not clear enough to allow good fundus photography
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franck Bacin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CRNH Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <state>Auvergne</state>
        <zip>63009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2007</study_first_submitted>
  <study_first_submitted_qc>March 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2007</study_first_posted>
  <last_update_submitted>October 5, 2011</last_update_submitted>
  <last_update_submitted_qc>October 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2011</last_update_posted>
  <keyword>visual caracteristics</keyword>
  <keyword>macular pigment optical density</keyword>
  <keyword>visual acuity</keyword>
  <keyword>contrast sensibility</keyword>
  <keyword>lutein</keyword>
  <keyword>docosahexaenoic acid (DHA)</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

